Catalent, a global CDMO headquartered in Somerset, NJ, plans to cut approximately 300 employees in its Biologics and Pharma and Consumer Health segments as part of its restructuring plans to reduce costs and consolidate facilities. Employee and non-employee restructuring charges associated with Catalent’s plans to reduce costs, consolidate facilities, and optimize its infrastructure across the organization were $30 million in the company’s fiscal second quarter and $17 million thr...